Advertisement

Ernährung und Flüssigkeitssubstitution in der letzten Lebensphase

  • Michaela Werni-Kourik

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Argiles JM, Meijsing SH, Pallares-Trujillo J et al (2001) Cancer cachexia: a therapeutic approach. Med Res Rev 21: 83–101PubMedCrossRefGoogle Scholar
  2. 2.
    Barber MD, Ross JA, Fearon KC (1999) Cancer cachexia. Surg Oncol 8: 133–141PubMedCrossRefGoogle Scholar
  3. 3.
    Bausewein C, Roller S, Voltz R (2000) Leitfaden Palliativmedizin, Urban & Fischer, München, S 380–382Google Scholar
  4. 4.
    Bentley A, Boyd K (2001) Mangement of nausea and vomiting using clinical pictures. Palliative Medicine 15: 247–253PubMedCrossRefGoogle Scholar
  5. 5.
    Body JJ (1999) The symptom of anorexia-cachexia. Curr Opin Oncol 11: 255–260PubMedCrossRefGoogle Scholar
  6. 6.
    Bruera E (1997) Anorexia, cachexia and nutrition. Br Med J 315: 1219–1222Google Scholar
  7. 7.
    Bruera E (1998) Pharmacological treatment of cachexia: any progress? Support Cancer Care 6: 109–113CrossRefGoogle Scholar
  8. 8.
    Bruera E, Belzile M, Watanabe S, Fainsinger R (1996) Volume of hydration in terminal cancer patients. Supportive Care in Cancer 4: 147–150PubMedCrossRefGoogle Scholar
  9. 9.
    Bruera E, Neumann CM, Pituskin E et al (1999) Thalidomide in patients with cachexia due to terminal cancer: preliminary report. Ann Oncol 10: 857–859PubMedCrossRefGoogle Scholar
  10. 10.
    Burge FI (1993) Dehydration symptoms of palliative care. J Pain Symtom and Management 8: 454–464CrossRefGoogle Scholar
  11. 11.
    Chance WT, Balasumbramaniam A, Dayal R et al (1994) Hypothalamic concentration and release of neuropeptide Y in microdialysates is reduced in anorectic tumor-bearing rats. Life Sci 54: 1869–1874PubMedCrossRefGoogle Scholar
  12. 12.
    Clemm C (2001) Ernährungstherapie. In: Höffken K, Kolb G, Wedding U (Hrsg), Geriatrische Onkologie. Springer, Berlin Heidelberg New York Tokyo, S 357–368Google Scholar
  13. 13.
    Davis MP, Dickerson D (2000) Cachexia and anorexia: cancer’s covert killer. Supportive Care in Cancer 8: 180–187PubMedCrossRefGoogle Scholar
  14. 14.
    Dunphy K, Finlay I, Rathborne G, Gilbert J, Hicks F (1995) Rehydration in palliative and terminal care: if not — why not? Palliative Medicine 9: 221–228PubMedGoogle Scholar
  15. 15.
    Fainsinger R (1996) Pharmacological approach to cancer anorexia and cachexia. In: Bruera E, Higginson I (Hrsg), Cachexia-anorexia in cancer patients. Oxford University Press, Oxford, S 128–140Google Scholar
  16. 16.
    Fainsinger RL, Bruera E (1997) When to treat dehydration in a terminally ill patients. J Palliative Care 10: 55–59Google Scholar
  17. 17.
    Fainsinger RL, MacEachern T, Miller M, Bruera E, Spachynsky K, Kuehn N, Hanson J (1994) The use of hypodermoclysis for rehydration in terminally ill cancer patients. J Pain and Symptom Management 9: 298–302CrossRefGoogle Scholar
  18. 18.
    Farrand S, Campell AJ (1996) Safe, simple subcutaneous fluid administration. Br J Hosp Med 55: 690–692PubMedGoogle Scholar
  19. 19.
    Feuz A, Rapin CH (1994) An observational study of the role of pain control and food adaption of elderly patients with terminal cancer. J Am Diet Assoc 94: 767–770PubMedCrossRefGoogle Scholar
  20. 20.
    Fox ET (1996) IV hydration in the terminally ill: ritual or therapy? Br J Nurse 5: 41–45Google Scholar
  21. 21.
    Gagnon B, Bruera E (1998) A review of the drug treatment of cachexia associated with cancer. Drugs 55: 675–688PubMedCrossRefGoogle Scholar
  22. 22.
    Gayle D, Ilyin SE, Plata-Salaman CR (1997) Central nervous system IL-1b system and neuropeptide Y mRNA during IL-1b-induced anorexia in rats. Brain Res Bull 44: 311–317PubMedCrossRefGoogle Scholar
  23. 23.
    Higginson I, Bruera E (1996) Practical concepts for clinicians. In: Bruera E, Higginson I (Hrsg), Cachexie-anorexia in cancer patients. Oxford University Press, Oxford, S 185–189Google Scholar
  24. 24.
    Hirai K, Hussey HJ, Barber MD et al (1998) Biological evaluation of a lipid-mobilizing factor isolated from the urine of cancer patients. Cancer Res 58: 2359–2365PubMedGoogle Scholar
  25. 25.
    Husebo S, Klaschik E (2000) Flüssigkeitssubstitution in der Terminalphase in Palliativmedizin. Springer, Berlin Heidelberg New York Tokyo, S 249–251Google Scholar
  26. 26.
    Inui A (1999a) Cancer anorexia-cachexia syndrome: are neuropeptids the key? Cancer Res 59: 4494–4501Google Scholar
  27. 27.
    Inui A (1999b) Feeling and body-weight regulation by hypothalamic neuropeptides — mediation of the of the actions of leptin. Trends Neurosci 22: 62–67PubMedCrossRefGoogle Scholar
  28. 28.
    Inui A (1999c) Neuropeptide Y. A key molecule in anorexia and cachexia in wasting disorders? Mol Med Today 5: 79–85PubMedCrossRefGoogle Scholar
  29. 29.
    Kalra SP, Cube MG, Pu S et al (1999) Interacting appetite-regulating pathways in the hypothalamic regulation of body weight. Endocr Rev 20: 68–100PubMedCrossRefGoogle Scholar
  30. 30.
    Kaye P (1994) Nausea and vomiting. In: A to Z of hospice and palliative medicine. EPL Publication, Northhampton, S 159–164Google Scholar
  31. 31.
    Klein S, Kinney J, Jeejeebhoy K et al (1997) Nutrion support in clinical practice: review of published data recommendations for the future research directions. Am J Clin Nutr 66: 683–706PubMedGoogle Scholar
  32. 32.
    Kotler DP (2000) Cachexia. Ann Intern Med 133: 622–634PubMedGoogle Scholar
  33. 33.
    Lissoni P, Paolorossi F, Tancini G et al (1996) Is there a role for melatonin in the treatment of neoplastic cachexia? Eur J Cancer 32: 1340–1343CrossRefGoogle Scholar
  34. 34.
    Loprinzi CL, Michalak JC, Schaid DJ et al (1993) Phase III evaluatio of four doses of megestrol acetate as therapy for patients with cancer anorexia and/or cachexia. J Clin Oncol 11: 762–767PubMedGoogle Scholar
  35. 35.
    Ludwig CA (1997) Flüssigkeitssubstitution in der Terminalphase. In: Aulbert E, Zech D (Hrsg) Lehrbuch der Palliativmedizin. Schattauer, Stuttgart, S 595–599Google Scholar
  36. 36.
    Mantovani G, Maccio A, Massa E et al (2001) Managing cancer-related anorexia/cachexia. Drugs 61: 499–514PubMedCrossRefGoogle Scholar
  37. 37.
    Musgrave CT, Bartal N, Opstad J (1995) The sensation of thirst in dying patients receiving IV hydration. J Palliative Care 11: 17–21Google Scholar
  38. 38.
    Nelson KA (2000) The cancer anorexia-cachexia syndrome. Semin Oncol 27: 64–68PubMedGoogle Scholar
  39. 39.
    Nelson K, Walsh D, Deeter P et al (1994) A phase II study of delta-9-tetrahydrocannabinol for appetite stimulation in cancer associated anorexia. J Palliat Care 10: 14–18PubMedGoogle Scholar
  40. 40.
    Ollenschläger G (1997) Tumorkachexie und Ernährung. In: Aulbert E, Zech D (Hrsg), Lehrbuch der Palliativmedizin. Schattauer, Stuttgart, S 556–565Google Scholar
  41. 41.
    Schwartz MW, Seeley RJ (1997) Neuroendocrine responses to starvation and weight loss. N Engl J Med 226: 1802–1811CrossRefGoogle Scholar
  42. 42.
    Schwartz MW, Woods SC, Porte D et al (2000) Central nervous system control for food intake. Nature 404: 661–671PubMedGoogle Scholar
  43. 43.
    Smith KL, Tisdale MJ (1993) Increased protein degradation and decreased protein synthesis in skeletal muscle during cancer cachexia. Br J Cancer 67: 680–685PubMedGoogle Scholar
  44. 44.
    Tisdale MJ (2000) Metabolic abnormalities in cachexia and anorexia. Nutrition 16: 1013–1014PubMedCrossRefGoogle Scholar
  45. 45.
    Tisdale MJ (2001) Cancer anorexia and cachexia. Nutrition 17: 438–442PubMedCrossRefGoogle Scholar
  46. 46.
    Todorov P, Cariuk P, McDevitt et al (1996) Characterization of a cancer cachectic factor. Nature 379: 739–742PubMedCrossRefGoogle Scholar
  47. 47.
    Werni M, Wilkens E, Popp W (2002) Ziel: Verbesserung der Lebensqualität — Ernährung und Flüssigkeitssubstitution in der Palliativmedizin. Wien Klin Wochenschr 3a: 26–30Google Scholar
  48. 48.
    Wigmore MJ, Ross JA, Falconer JS et al (1996) The effect of polyunsaturated fatty acids on the progress of cachexia in patients with pancreatic cancer. Nutrition 12: 27–30Google Scholar
  49. 49.
    Wigmore SJ, Fearon KC, Maingay JP et al (1997a) Down-regulation of the acute-phase response in patients with pancreatic cancer cachexia receiving oral eicosapentaenoic acid is mediated via suppression of interleukin-6. Clin Sci 92: 215–221PubMedGoogle Scholar
  50. 50.
    Wigmore SJ, Plester CE, Ross JA et al (1997b) Contribution of anorexia and hypermetabolism to weight loss in anicteric patients pancreatic cancer. Br J Surg 84: 196–197PubMedCrossRefGoogle Scholar
  51. 51.
    Woods SC, Seeley RJ, Porte D et al (1998) Signals that regulate food intake and energy homeostasis. Science 280: 1378–1383PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag/Wien 2006

Authors and Affiliations

  • Michaela Werni-Kourik
    • 1
  1. 1.Ärztl. Leiterin d. Station f. Palliativmed. KH LainzWien

Personalised recommendations